Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02779478 · ClinicalTrials.gov registry record
Evaluation Of The Lung Microbiome In NTM Bronchiectasis
A clinical trial of Bronchiectasis and Nontuberculous Mycobacteria, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT02779478 is a study of Bronchiectasis and Nontuberculous Mycobacteria that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 1,000 participants, above the 311-participant average among 13 other Bronchiectasis trials with a reported enrollment target (222% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02779478, a study of Bronchiectasis and Nontuberculous Mycobacteria, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
A biomarker cohort study design is proposed to study whether specific airway microbiota alterations are associated with pulmonary Non-tuberculous mycobacteria (NTM) disease. In a cohort of 200 subjects suspected of having pulmonary NTM disease, the investigators will evaluate the airway microbiome using an aliquot of the induced sputum and upper airway samples. Since induced sputum may reflect different regions of the upper/lower airways, the investigators will evaluate the upper and lower airway microbiome in a subgroup (case-control group) of patients using samples obtained through upper airway sampling and bronchoscopy, respectively.
Conditions Studied
Interventions
- PROCEDURE Bronchoscopy
Study Locations (1)
New York
- New York University School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2014-10-01 |
| Est. Completion | 2031-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02779478
The ClinicalTrials.gov registry entry for NCT02779478 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 311-participant average among 13 other Bronchiectasis trials with a reported enrollment target (222% higher). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Bronchiectasis appearing as the primary indexed condition, and to 1 intervention - of which Bronchoscopy is the first listed.
NCT02779478 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02779478 about?
NCT02779478 is a clinical study titled "Evaluation Of The Lung Microbiome In NTM Bronchiectasis". A biomarker cohort study design is proposed to study whether specific airway microbiota alterations are associated with pulmonary Non-tuberculous mycobacteria (NTM) disease. In a cohort of 200 subjects suspected of having pulmonary NTM disease, the investigators will evaluate the airway microbiome u...
What is the current status of trial NCT02779478?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2014-10-01. Estimated completion is 2031-07.
What conditions does trial NCT02779478 study?
This clinical trial studies the following conditions: Bronchiectasis, Nontuberculous Mycobacteria.
What interventions are being tested in trial NCT02779478?
The interventions under investigation include: Bronchoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT02779478?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02779478 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bronchiectasis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
RECRUITING · Phase 3
-
Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease
RECRUITING · NA
-
Itraconazole Therapy In Bronchiectasis With Airway Mold
RECRUITING · Phase 4
-
OLE Therapy With BE Patients in Home Care Study
RECRUITING · NA
-
Natural History of Bronchiectasis
RECRUITING
-
Acoustic Waveform Respiratory Evaluation
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.